| | |

Deep Vein Thrombosis After Pleurectomy for Mesothelioma

deep vein thrombosis after pleurectomy

The authors of a new study on deep vein thrombosis after pleurectomy say mesothelioma patients may be at special risk. They say routine screening after pleural mesothelioma surgery could save lives.

The study comes from Brigham and Women’s Hospital, a leader in cancer research. The research team followed a series of mesothelioma patients who agreed to be part of a DVT surveillance program. 

Nearly 30 percent of the patients experienced deep vein thrombosis after pleurectomy. A third of those patients had no symptoms.

Understanding DVT 

Deep vein thrombosis or DVT is when a blood clot forms in the deep veins of the arm, leg, or groin. If the clot goes unnoticed, it can travel through the circulation and lodge in the lungs. Clots that lodge in a pulmonary artery of the lungs can cause a pulmonary embolism (PE). PE can be fatal. 

Deep vein thrombosis after pleurectomy or another major surgery is not uncommon. Having cancer raises the risk even higher. 

Monitoring with ultrasound can sometimes find a clot before it becomes a major problem. But there are no guidelines about screening for DVT in mesothelioma surgery patients. 

Screen for Deep Vein Thrombosis After Pleurectomy

Pleural mesothelioma is a malignancy that affects the membrane around the lungs. There is no cure for pleural mesothelioma. If the tumor is contained, patients who are in otherwise good health may undergo pleurectomy. 

Pleurectomy with decortication (P/D) is a major operation during which surgeons remove the whole pleural membrane and other at-risk tissues in the chest. Deep vein thrombosis after pleurectomy is a serious threat. 

The new study included 93 mesothelioma patients who had P/D surgery. Patients without symptoms had ultrasound screening for DVT every 7 days after surgery. If a patient had DVT symptoms, screening happened earlier. 

Twenty-seven percent of the patients developed deep vein thrombosis after pleurectomy. Seven of those patients also had a pulmonary embolism. A third of the patients with DVT had no symptoms. The problem would have gone unnoticed without the screening. 

If a patient had DVT, they started on a blood thinner called heparin. Only a small percentage of patients developed bleeding problems from the treatment. 

“Up to 33% of patients with DVT are asymptomatic at the time of diagnosis, and the incidence of complications related to anticoagulation is low,” writes lead author Luis E.De León, MD. 

Dr. De León and his colleagues recommend routine ultrasound screening for mesothelioma patients after surgery. They say it may help find and treat deep vein thrombosis after pleurectomy “before it progresses to symptomatic or fatal PE.”

Source:

De León, et al, “Routine Surveillance for Diagnosis of Venous Thromboembolism After Pleurectomy for Malignant Pleural Mesothelioma”, January 30, 2020, Journal of Thoracic and Cardiovascular Surgery, Epub ahead of print, https://www.sciencedirect.com/science/article/abs/pii/S0022522320302348

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | |

    A Second-Line Option for Mesothelioma?

    Although survival was not significantly extended, the chemotherapy drug vinorelbine might be a treatment option for mesothelioma patients whose cancer has returned after first-line chemotherapy with pemetrexed. A new study on vinorelbine as a second-line treatment finds that the drug is “moderately active” in mesothelioma patients who were initially treated with pemetrexed-based chemotherapy. Pemetrexed (Alimta), along with a platinum-based drug like cisplatin, is the primary first-line drug therapy for mesothelioma. But vinorelbine is gaining attention as a possible option for mesothelioma, in part because it is available in a less expensive generic form. In “Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma”, the Italian authors detail the results of their study on 59 patients with unresectable pleural mesothelioma.  These patients…

  • | |

    Repeat HIPEC Improves Mesothelioma Survival

    If one cytoreductive surgery and HIPEC procedure for mesothelioma is good, subsequent treatments may be even better. That is the central message of research conducted at the Moffitt Cancer Center in Florida. The study’s aim was to assess overall survival among peritoneal mesothelioma patients who had not just one, but two or more rounds of heated intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The cytoreduction/HIPEC approach has become popular for peritoneal mesothelioma, a treatment-resistant cancer of abdominal membranes caused by asbestos. Cytoreductive surgery involves removing as much of the mesothelioma tumor as possible from the abdomen. Because the shape and spreading pattern of mesothelioma tumors make complete cytoreduction difficult, the surgery is often followed by a rinse with a heated solution…